|
FIRST INTERNATIONAL SYMPOSIUM ON ALBUMINURIA TO BE HELD IN
NEW YORK CITY IN MAY 2004
Experts from around the world to lead discussions on the importance of a urinary protein in the identification and treatment of kidney and cardiovascular disease
NEW YORK, NY — January 15, 2003 –The National Kidney Foundation and the International Society of Nephrology announced today that they will organize a first-of-its kind, three-day event to discuss the role of a critical urinary protein as an independent disease marker and therapy target for kidney and cardiovascular disease. The urinary protein called albumin is increasingly recognized as the earliest sign of vascular damage in both the kidney and the heart. The symposium will focus on increasing awareness of the importance of identifying excess amounts of the protein albumin in urine, a warning sign of potential kidney and cardiovascular disease. During the event, some of the world?s most prominent experts will present to the international medical community the most up-to-date information on the role of albuminuria and how results of different tests for the condition can be used to detect and treat kidney disease and other serious conditions. The international symposium, entitled ?The Role of Albuminuria in Health and Disease; Predicting Outcomes and Targets for Therapy,? will take place on May 16-18, 2004. It is organized by the National Kidney Foundation and the International Society of Nephrology with the support of the American Society of Nephrology and the Juvenile Diabetes Research Foundation. Download and read the complete press release in PDF* . * To view the PDF file you need Adobe Acrobat Reader. Free download available . |